Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
83.1M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
42M
-
Shares change
-
-83.6K
-
Total reported value, excl. options
-
$376M
-
Value change
-
-$24.1M
-
Put/Call ratio
-
0.83
-
Number of buys
-
50
-
Number of sells
-
-50
-
Price
-
$8.94
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) as of Q4 2022
126 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42M shares
of 83.1M outstanding shares and own 50.58% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.45M shares), RTW INVESTMENTS, LP (4.24M shares), EcoR1 Capital, LLC (3.56M shares), COWEN AND COMPANY, LLC (3.14M shares), BlackRock Inc. (2.55M shares), STATE STREET CORP (2.28M shares), Abingworth LLP (2.12M shares), VANGUARD GROUP INC (1.69M shares), MORGAN STANLEY (1.63M shares), and Polar Capital Holdings Plc (1.26M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.